Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
13.24M 10.12M 22.79M 33.67M 314.17M 329.72M 132.32M 157.28M 62.63M 50.3M 15.37M 59.03M 54.83M 71.77M 131.65M 157.54M 155.03M 49.29M
Short-Term Investments
244.15M 253.11M 252.45M 247.45M 46.54M 47.31M 41.39M 32.59M 14.96M 29.68M 60.13M 69.26M 84.59M 84.84M 45.28M 35.08M 52.77M 83M
Long-Term Investments
51.7M 68.31M 81.73M 61.48M 66K 66K 66K 65K n/a n/a 1.78M 1.78M 1.78M 1.78M 1.78M 1.78M 1.78M n/a
Other Long-Term Assets
9.18M 7.63M 9.63M 4.74M 2.58M 745K 1.09M 51K n/a n/a -1.66M n/a n/a n/a n/a n/a n/a 1.78M
Receivables
139K 1M 807K 1.29M 1.68M 876K 478K 751K n/a n/a 5.64M n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 852K n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
6.08M 392K 1.13M 1.39M n/a n/a 2.66M 812K 1.04M 3.46M 53K 3.81M 2.62M 3.63M 3.77M 3.86M 2.38M 2.81M
Total Current Assets
263.61M 271M 280.9M 287.49M 365.69M 380.93M 177.45M 191.45M 78.64M 83.44M 82.03M 132.1M 142.04M 160.24M 180.69M 196.47M 210.19M 135.1M
Property-Plant & Equipment
1.58M 1.64M 1.75M 541K 631K 725K 800K 893K n/a n/a 956K 30.25M 31.3M 32.37M 7.46M 7.98M 8.41M 7.74M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
62.47M 77.58M 93.1M 66.76M 3.27M 1.54M 1.95M 1.01M n/a n/a 1.08M 32.03M 33.08M 34.15M 9.24M 9.76M 10.19M 9.52M
Total Assets
326.08M 348.58M 374.01M 354.25M 368.96M 382.46M 179.41M 192.46M 78.64M 83.44M 83.11M 164.12M 175.12M 194.38M 189.93M 206.24M 220.38M 144.62M
Account Payables
5.4M 8.27M 4.58M 7.57M 3.69M 2.61M 2.61M 1.37M 813K 1.08M 1.17M 2.58M 2.05M 4.44M 3.04M 1.89M 2.93M 2.11M
Deferred Revenue
479K 479K 479K 100K 100K 100K 100K 100K n/a n/a 100K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
211K n/a n/a n/a 377K 400K 417K 413K n/a n/a n/a 3.62M 3.42M 3.25M n/a n/a n/a n/a
Other Current Liabilities
10.19M 2.05M 5.15M 7.73M 2.88M 4M 4.94M 6.36M 1.6M 3.28M 2.08M 3.44M 3.58M 4.78M 4.48M 5.28M 6.03M 5.94M
Total Current Liabilities
20.09M 16.95M 18.45M 15.71M 10.03M 8.96M 9.63M 13.08M 4.03M 5.98M 8.22M 12.92M 11.26M 14.09M 10.86M 10.15M 11.08M 9.21M
Long-Term Debt
1.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 27.18M 28.19M 29.1M n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -27.18M -28.19M -29.1M 6.4M 6.4M 6.4M 6.36M
Total Long-Term Liabilities
2.9M 3.02M 3.08M 640K 712K 816K 904K 1M n/a n/a 119.25M 27.18M 28.19M 29.1M 6.4M 6.4M 6.4M 6.36M
Total Liabilities
23M 19.97M 21.53M 16.35M 10.74M 9.78M 10.54M 14.08M 4.03M 5.98M 127.48M 40.1M 39.44M 43.2M 17.26M 16.55M 17.49M 15.56M
Total Debt
1.33M 1.4M 1.49M 311K 407K 497K 585K 670K n/a n/a 788K 30.8M 31.61M 32.35M n/a n/a n/a n/a
Common Stock
32K 32K 31K 29K 29K 29K 15K 15K 61K 61K 61K 61K 59K 59K 59K 59K 59K 49K
Retained Earnings
-235.53M -203.9M -174.39M -145.95M -120.78M -103.17M -89.42M -78.86M -434.48M -431.2M -45.87M -381.85M -365.79M -348.52M -325.57M -306.27M -288.85M -271.92M
Comprehensive Income
98K 270K 106K 681K -37K -27K 47K -4K -3K -16K -161K -462K -602K -469K -30K 1K 2K 9K
Shareholders Equity
303.08M 328.61M 352.48M 337.9M 358.22M 372.69M 168.87M 178.38M 74.6M 77.46M -44.37M 124.03M 135.68M 151.19M 172.67M 189.69M 202.89M 129.06M
Total Investments
295.86M 321.42M 334.18M 308.93M 46.6M 47.38M 41.46M 32.59M 14.96M 29.68M 60.13M 71.04M 86.37M 86.62M 47.06M 36.86M 54.55M 83M